Andrew Gardiner CEO
Over the past two decades, Andrew has built a successful career in the pharmaceutical industry having held senior commercial positions in both large and small life science organisations including Pharmacia and ProStrakan. The combination of his commercial and R&D experience has enabled him to develop, and launch, numerous, well differentiated products to global audiences.
As Chief Executive Officer (and a founding director) Andrew is responsible for all operational matters.
Management Team and Board of Directors
The Syntropharma Board have many years experience of the Life Science sector.
Our collective mission is to create new treatment options for the large number of people with unmet medical needs in the Psychiatric and Central Nervous System space.
Enthusiasm, drive and commitment have been key attributes in the Companies development.
Syntropharma are actively seeking an appropriate partner to assist in the commercialisation of this opportunity in the EU.